Propylene Glycol & PROPYLENE GLYCOL Excipient Use in Tablet Delayed Release Dosage Forms

Propylene Glycol

FDA Inactive Ingredient Details, DESCRIPTION

Suppliers

3 Listed Products, 1 Nanjing Well Pharmaceutical, 1 BASF, 1 Finar

REGULATORY FILINGS

1 Suppliers, 1 USDMF

SOLUTIONS BY APPLICATIONS

2 Film Formers & Plasticizers, 2 Topical, 1 Parenteral, 1 Solubilizers, 1 Fillers, Diluents & Binders, 1 Thickeners and Stabilizers

ANALYTICAL SOLUTION(s)

9 Other Ref. Standards

9 Other Ref. Standards

FINISHED FORMULATIONS

901 ORAL, 350 CAPSULE, 273 TOPICAL, 142 SOLUTION, 125 TABLET, 111 CREAM, 77 TABLET, EXTENDED RELEASE, 63 CAPSULE, EXTENDED RELEASE, 45 GEL, 42 CAPSULE, DELAYED REL PELLETS, 39 INJECTABLE, 38 TABLET, DELAYED RELEASE, 37 SYRUP, 36 INJECTION, 35 SUSPENSION, 34 OINTMENT, 28 LOTION, 18 VAGINAL, 13 AEROSOL, FOAM, 11 FOR SUSPENSION, 10 CAPSULE, DELAYED RELEASE, 8 INTRAVENOUS, 8 OTIC, 8 SOLUTION/DROPS, 5 CONCENTRATE, 5 SUSPENSION, EXTENDED RELEASE, 5 SUSPENSION/DROPS, 5 TOPICAL, VAGINAL, 4 CREAM, AUGMENTED, 4 OPHTHALMIC, 4 SWAB, 4 TABLET, CHEWABLE, 3 AEROSOL, METERED, 3 ELIXIR, 3 FILM, 3 ORAL, RECTAL, 3 PATCH, 3 RECTAL, 3 TABLET, ORALLY DISINTEGRATING, 3 TRANSDERMAL, 2 BUCCAL, 2 CAPSULE, TABLET, CAPSULE, DELAYED REL PELLETS, 2 CREAM, INSERT, 2 DENTAL, 2 GEL, METERED, 2 LOTION, AUGMENTED, 2 SPRAY, METERED, 2 SUPPOSITORY, 1 BUCCAL, SUBLINGUAL, 1 CREAM, SUPPOSITORY, 1 GEL, AUGMENTED, 1 INTRA-ANAL, 1 IV (INFUSION), 1 NASAL, 1 OINTMENT, AUGMENTED, 1 PASTE, 1 POWDER, 1 SPRAY, 1 SUBCUTANEOUS, 1 SYSTEM, 1 TABLET, COATED PARTICLES, 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE, 1 TRANSMUCOSAL, 1 TROCHE/LOZENGE